This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1328 entries already.
A small prospective study among mid-aged people has demonstrated that a mild SARS-CoV-2 infection triggers ME/CF in 50% of the study population.<button lang="en-GB" aria-description="Klicken, um Alternative zu verwenden"></button>
Swedish food and feed supplement specialist Bactolife A/S has received US$5m in funding from the Bill & Melinda Gates Foundation to address gastrointestinal infections.
For the second time within a short period of time, a competitor has sued the mRNA vaccine developer BioNtechPfizer for patent infringement.
Moderna co-founder Kenneth Chien and Novalis LifeSciences LLC are the lead investors of a 39m Series B2 financing in eTheRNA.
Kinarus Therapeutics Holding AG has raised US$20m in financing through the issuance of convertible bonds to YA II PN, Ltd.
A study in the scientific journal The Lancet shows that half of all global cancer deaths are due to life style-related risk factors such as smoking and alcohol use.
Polish cancer drug developer, Ryvu Therapeutics, has received 22m funding from the European Investment Bank via its venture debt instrument.
Avantium and AmBev, part of AB InBev Group, have inked an agreement on PEF for soft drink bottles.
With a Series A funding of CHF 30m from Versant Ventures, Vector Biopharma AG set out to solve several of the current gene delivery problems.
Swiss-headquarterd Novartis AG has reported two cases of fatal liver failure after treatment with the gene therapy Zolgensma.